Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-06

Clinical Trial Update: Transrectal Tumour Oxygen - US Army [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating transrectal tumour oxygen for prostatic neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED